PL324897A1 - Proteinous allergen-xcd32 fusions - Google Patents

Proteinous allergen-xcd32 fusions

Info

Publication number
PL324897A1
PL324897A1 PL96324897A PL32489796A PL324897A1 PL 324897 A1 PL324897 A1 PL 324897A1 PL 96324897 A PL96324897 A PL 96324897A PL 32489796 A PL32489796 A PL 32489796A PL 324897 A1 PL324897 A1 PL 324897A1
Authority
PL
Poland
Prior art keywords
xcd32
proteinous
allergen
fusions
xcd32 fusions
Prior art date
Application number
PL96324897A
Inventor
Geert C Mudde
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL324897A1 publication Critical patent/PL324897A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL96324897A 1995-08-16 1996-08-16 Proteinous allergen-xcd32 fusions PL324897A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Publications (1)

Publication Number Publication Date
PL324897A1 true PL324897A1 (en) 1998-06-22

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96324897A PL324897A1 (en) 1995-08-16 1996-08-16 Proteinous allergen-xcd32 fusions

Country Status (16)

Country Link
EP (1) EP0846178A1 (en)
JP (1) JPH11513025A (en)
KR (1) KR19990036440A (en)
CN (1) CN1193353A (en)
AU (1) AU6873596A (en)
BR (1) BR9610239A (en)
CA (1) CA2227795A1 (en)
CZ (1) CZ43798A3 (en)
GB (1) GB9516760D0 (en)
HU (1) HUP9802349A3 (en)
IL (1) IL122898A0 (en)
NO (1) NO980566L (en)
PL (1) PL324897A1 (en)
SK (1) SK19398A3 (en)
TR (1) TR199800214T1 (en)
WO (1) WO1997007218A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
WO1999028349A2 (en) 1997-12-02 1999-06-10 Medarex, Inc. CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (en) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Device for selective suppression of pathologic dna-specific b cells
BG65954B1 (en) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Means for selective suppression of the activity of pathologic autoreactive b-cells
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
DK2861240T3 (en) 2012-06-15 2020-09-28 Immunomic Therapeutics Inc NUCLEIC ACIDS FOR THE TREATMENT OF ALLERGIES
US10434170B2 (en) 2012-07-13 2019-10-08 S-Target Therapeutics Gmbh Immunoregulatory vaccine
WO2014067993A1 (en) * 2012-11-01 2014-05-08 Veterinærinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
CA2912736C (en) 2013-05-21 2021-09-07 Tyg Oncology Ltd. Gastrin peptide immunogenic composition
CN113186167B (en) * 2021-04-28 2021-11-30 中国食品药品检定研究院 Method for determining biological activity of anti-CD 20 monoclonal antibody drug ADCP

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
AU2670995A (en) * 1994-05-26 1995-12-21 Innogenetics N.V. New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
IL122898A0 (en) 1998-08-16
NO980566D0 (en) 1998-02-10
MX9801253A (en) 1998-05-31
NO980566L (en) 1998-02-10
HUP9802349A2 (en) 1999-01-28
HUP9802349A3 (en) 1999-04-28
EP0846178A1 (en) 1998-06-10
TR199800214T1 (en) 1998-06-22
KR19990036440A (en) 1999-05-25
CA2227795A1 (en) 1997-02-27
CN1193353A (en) 1998-09-16
BR9610239A (en) 1999-06-15
GB9516760D0 (en) 1995-10-18
CZ43798A3 (en) 1998-06-17
JPH11513025A (en) 1999-11-09
SK19398A3 (en) 1998-09-09
WO1997007218A1 (en) 1997-02-27
AU6873596A (en) 1997-03-12

Similar Documents

Publication Publication Date Title
HUP9800299A3 (en) Gnrh-leukotoxin chimeras
PL324897A1 (en) Proteinous allergen-xcd32 fusions
HU9502378D0 (en) Substituted biphenyl-oxazolinones
ZA954095B (en) Substituted 3-phenylpyrazoles
GB9510830D0 (en) Proteins
ZA96237B (en) Substituted 2-pheylpyridines
ZA956011B (en) Substituted triazolylmethylphenylnaphthyridones
ZA954546B (en) Substituted 3-phenylpyrazoles
AU127523S (en) Scissors
IL115317A0 (en) Proteins
ZA96238B (en) Substituted 2-pheylpyridines
AU4286296A (en) Halofluorocarbon hydrogenolysis
GB9517125D0 (en) Scissors
GB9526613D0 (en) Sequence
TW303582U (en) Blade-exchangeable scissors
GB9509814D0 (en) Connecting means
HK1016175A1 (en) Substituted phenyluracils
DE69628581D1 (en) Heparinchromatographie von erythropoietinen
GB9521405D0 (en) An autoclave
GB9503380D0 (en) Substituted azo-dicarbonylo deriratives
GB9506678D0 (en) Substituted 6-azacholesten-3-ones
ZA951092B (en) Substituted oxazacycloalkenes
EG21472A (en) Low hue photodisinfectants
GB2300830B (en) Knife
CA77514S (en) Knife